Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check3 days agoChange DetectedThe revision label on the page updated from v3.5.3 to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedUpdate of the ClinicalTrials.gov page revision indicator from “v3.5.2” to “v3.5.3,” reflecting a platform/version change without altering the study’s recorded content.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the history.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, and v3.4.3 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.SummaryDifference0.1%

- Check96 days agoChange DetectedA new revision entry v3.4.2 was added to the record history, and the entry for v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.